Biomarkers for Schizophrenia Or Other Psychotic Disorders
The invention relates to a method of diagnosing or monitoring schizophrenia or other psychotic disorder.
Schizophrenia is a psychiatric diagnosis that describes a mental disorder characterized by abnormalities in the perception or expression of reality. It most commonly manifests as auditory hallucinations, paranoid or bizarre delusions, or disorganized speech and thinking with significant social or occupational dysfunction. Onset of symptoms typically occurs in young adulthood, with approximately 0.4-0.6% of the population affected . Diagnosis is based on the patient's self-reported experiences and observed behavior. No laboratory test for schizophrenia currently exists.
BAHN SABINE [GB]; LEVIN YISHAI [GB]
Type of Offer:
« More Mental Health Patents« More Diagnostic Patents